Your browser doesn't support javascript.
loading
Human papillomavirus vaccination coverage, policies, and practical implementation across Europe.
Nguyen-Huu, Ngoc-Ha; Thilly, Nathalie; Derrough, Tarik; Sdona, Emmanouela; Claudot, Frédérique; Pulcini, Céline; Agrinier, Nelly.
Afiliação
  • Nguyen-Huu NH; Université de Lorraine, Apemac, F-54000 Nancy, France.
  • Thilly N; Université de Lorraine, Apemac, F-54000 Nancy, France; CHRU Nancy, Université de Lorraine, Plateforme d'Aide à la Recherche Clinique, F-54000 Nancy, France.
  • Derrough T; European Centre for Disease Prevention and Control, Sweden.
  • Sdona E; European Centre for Disease Prevention and Control, Sweden.
  • Claudot F; Université de Lorraine, Apemac, F-54000 Nancy, France.
  • Pulcini C; Université de Lorraine, Apemac, F-54000 Nancy, France; Université de Lorraine, CHRU-Nancy, Infectious Diseases Department, F-54000 Nancy, France.
  • Agrinier N; Université de Lorraine, Apemac, F-54000 Nancy, France; CHRU-Nancy, INSERM, Université de Lorraine, CIC, Epidémiologie Clinique, F-54000 Nancy, France. Electronic address: n.agrinier@chru-nancy.fr.
Vaccine ; 38(6): 1315-1331, 2020 02 05.
Article em En | MEDLINE | ID: mdl-31836255
ABSTRACT

BACKGROUND:

Our objectives were to describe Human Papillomavirus vaccination coverage rates (HPV-VCR), policies, and practical steps for programme implementation that may be linked to high uptake in the population targeted by routine programmes across 30 European Union/European Economic Area Member States and Switzerland.

METHODS:

Information from institutional websites and from articles indexed in Medline between 01/2006 and 01/2017 was reviewed and extracted using a standardised form. In 12/2017, a cross-sectional survey was administered to national experts, in order to update the compiled information.

RESULTS:

Data were available in 31 countries, and validated by national experts in 28 of them. National vaccination programmes targeted girls 9-15 years of age in 30 countries and boys in 11 countries. HPV-VCR in girls was monitored in 25 countries VCR was reported ≥71%(high) in ten countries, 51-70% in seven, 31-50% in four, and ≤30%(very low) in four. In high VCR countries, HPV vaccination was mainly delivered through school health services, and invitation and reminders to attend for vaccination were used. In areas with very low VCR, vaccination tended to be opportunistic and no reminders were used.

CONCLUSION:

According to our findings, school delivery within structured vaccination programmes and the use of reminders tended to be associated with highest HPV-VCR.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Cobertura Vacinal / Vacinas contra Papillomavirus Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Vaccine Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Cobertura Vacinal / Vacinas contra Papillomavirus Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Vaccine Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França